TY - CHAP A1 - Amanda G. Linkous A2 - Eugenia M. Yazlovitskaya ED1 - Sophia Ran Y1 - 2012-02-17 PY - 2012 T1 - New Molecular Targets for Anti-Angiogenic Therapeutic Strategies N2 - Tumor angiogenesis is the main process responsible for the formation of new blood vessels that promote tumor growth and metastasis. This process is driven by potent pro-angiogenic factors that are predominant in the tumor environment and are produced by both malignant cells and the host cells recruited to the tumor site. Tumor environment is characterized by the imbalance between pro-angiogenic and anti-angiogenic factors, which drives the construction of numerous but structurally defective vessels. These poorly perfused and abnormal vessels significantly contribute to the tumor pathology not only by supporting the expansion of the tumor mass but also by promoting chronic inflammation, enhancing thrombosis, impeding drug delivery, and disseminating tumor cells. These problems associated with tumor vasculature continue to attract great attention of scientists and clinicians interested in advancing the understanding of tumor biology and development of new drugs. This book complies a series of reviews that cover a broad spectrum of current topics related to the pathology of tumor blood vessels including mechanisms inducing new vessels, identification of new targets for inhibition of tumor angiogenesis, and potential clinical use of known and novel anti-angiogenic therapies. The book provides an update on tumor angiogenesis that could be useful for oncologists, cancer researchers and biologists with interests in vascular and endothelial cell behavior in the context of cancer. BT - Tumor Angiogenesis SP - Ch. 12 UR - https://doi.org/10.5772/26208 DO - 10.5772/26208 SN - PB - IntechOpen CY - Rijeka Y2 - 2021-09-25 ER -